Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Malignant Nail Tumors
Description
The presentation discusses malignant nail tumors, focusing on squamous cell carcinoma (SCC) and nail melanoma, emphasizing the importance of early detection and diagnostic techniques. Key indicators for suspecting malignancy include new formations around or under the nail, treatment failures, and signs of ulceration. SCC is the most common type of malignant nail tumor, known for its slow progression and a high likelihood of misdiagnosis due to its mimicry of benign conditions. Several clinical presentations and features identifiable through onychoscopy are highlighted, including color alterations and vascular changes. The presentation stresses the importance of distinguishing between benign and malignant lesions, with specific attention to painless presentations which may lead to delays in diagnosis. Additionally, nail melanoma, particularly in adults, is characterized by pigmentation that necessitates thorough evaluation, preferably using dermatoscopy, to determine if it's due to benign causes or malignancy. The ABC rule is suggested for assessing melanoma, focusing on asymmetry, border irregularities, and color variation. Prompt biopsy and surgical excision are recommended for any suspected malignancies to improve prognosis, underscoring the necessity of considering malignancy in any unusual nail presentation.
View moreConclusions
- Malignant nail tumors primarily include squamous cell carcinoma (SCC) and melanoma.
- SCC is the most common malignant nail tumor, usually presenting in adults aged 50-69 and often associated with oncogenic HPV, chronic trauma, and immunosuppression.
- SCC shows slow progression with a median diagnosis delay of about 10 years, often leading to bone invasion but with rare metastasis.
- Clinical features of SCC include painless erosion of the nail bed, lateral onycholysis, and warty growths, requiring careful differential diagnosis with conditions like pyogenic granuloma and melanoma.
- Onychoscopy reveals key alterations in color, structure, and vascularity that help differentiate SCC from benign conditions.
- Melanoma should be suspected in cases of longitudinal melanonychia, especially if associated with Hutchinson's sign, rapid growth, or nail plate abnormalities.
- Age and change patterns in pigmentation are crucial diagnostic factors for distinguishing between benign and malignant melanonychia.
- Histopathological evaluation is necessary to confirm the diagnosis of melanoma, particularly in longitudinal melanonychia cases without clear cause.
- Regular monitoring and proactive biopsy of suspicious pigmented lesions can lead to early and more effective treatment of malignant conditions.
- Teysseire et al. Dermatology 2017; 233: 184-191
- Starace et al. Dermatol Pract Concept 2018; 8: 237-243
- Haneke E. J Dtsch Dermatol Ges. 2017 Apr;15(4):367-386
- Jellinek NJ. J Am Acad Dermatol. 2011; 64: 167.e1-11
- Starace et al. Dermatol Pract Concept. 2018; 8: 238-244
- Piraccini BM et al. Dermatol Clin 2015; 33: 185-195
- Sato T, Tanaka M. Dermatol Pract Concept. 2014 Apr 30;4(2):83-5
- Braun RP, Baran R, Le Gal FA et al. J Am Acad Dermatol 2007; 56(5): 835-847
- Alessandrini A, Starace M, Piraccini BM. Dermoscopy in the evaluation of nail disorders. SAD 2017; 3(2):70-82
- Starace M, Alessandrini A, Brandi N, Piraccini BM. Dermatol Pract Concept. 2019 Jan 31;9(1):38-43
- Levit et al. J Am Acad Dermatol. 2000; 42: 269
- Ko et al. J Am Acad Dermatol. 2019; 80: 1272-1283
- Di Chiacchio et al A. An Bras Dermatol. 2013; 88: 309-13
- Ronger et al. Arch Dermatol.2002; 138: 1327-1333
- Thomas & Dalle Dermatol Ther. 2007; 20: 3-10
- Koga et al. J Dermatol. 2011;38: 45-52
- Ohn et al. JAMA Dermatol. 2018; 154: 890-896
- Baran R. Dermatologica 1987; 174: 280-4
- Alessandrini A et al. Management and outcome of Taxane-induced nail side effects: experience of 79 patients in a single centre. In press
- Tosti A, et J Am Acad Dermatol 1996;34:765-71
- Goettmann-Bonvallot S, et al. J Am Acad Dermatol 1999; 41 :17-22
- Starace M, Dika E, Fanti PA, Patrizi A, Misciali C, Alessandrini A, Bruni F, Piraccini BM. Nail Apparatus Melanoma: dermoscopic and histopathologic correlations on a series of 23 patients from a single center. JEADV 2017.